These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4623135)

  • 1. Insights into public assistance medical care expenditures.
    Hammel RW
    JAMA; 1972 Mar; 219(13):1740-4. PubMed ID: 4623135
    [No Abstract]   [Full Text] [Related]  

  • 2. Causes of increase in Medicaid costs in California.
    Gartside FE
    Health Serv Rep; 1973 Mar; 88(3):225-35. PubMed ID: 4632190
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for controlling the cost of state medical assistance programs.
    Harder RC; Smith CJ
    Public Welf; 1979; 37(2):39-49. PubMed ID: 10308877
    [No Abstract]   [Full Text] [Related]  

  • 4. A perspective on Medicaid.
    Levey S
    N Engl J Med; 1969 Aug; 281(6):297-301. PubMed ID: 4978371
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of SSI on Medicaid caseloads and expenditures.
    Hawkins SC; Rigby DE
    Soc Secur Bull; 1979 Feb; 42(2):3-14. PubMed ID: 108807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The social drug lag: an examination of pharmaceutical approval delays in Medicaid formularies.
    Schweitzer SO; Salehi H; Boling N
    Soc Sci Med; 1985; 21(10):1077-82. PubMed ID: 3909437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of restrictive formularies in the ambulatory care setting.
    Lexchin J
    Am J Manag Care; 2002 Jan; 8(1):69-76. PubMed ID: 11814174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PMA (Pharmaceutical Manufacturers Association) finances grassroots coalition to fight changes in Medicaid formularies.
    Gatty B
    Hosp Formul; 1993 Aug; 28(8):714, 713. PubMed ID: 10127749
    [No Abstract]   [Full Text] [Related]  

  • 9. Access and cost implications of state limitations on Medicaid reimbursement for pharmaceuticals.
    Schweitzer SO; Shiota SR
    Annu Rev Public Health; 1992; 13():399-410. PubMed ID: 1599596
    [No Abstract]   [Full Text] [Related]  

  • 10. The cost of NHI: comparing the AHA and health security plans.
    Trapnell GR
    Hosp Prog; 1977 Feb; 58(2):58-60, 84. PubMed ID: 401764
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
    Rothbard AB; Lee S; Blank MB
    J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug and medical cost effects of a drug formulary change with therapeutic interchange for statin drugs in a multistate managed Medicaid organization.
    Meissner B; Dickson M; Shinogle J; Reeder CE; Belazi D; Senevirante V
    J Manag Care Pharm; 2006 May; 12(4):331-40. PubMed ID: 16792439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foundations for Medical Care.
    Egdahl RH
    N Engl J Med; 1973 Mar; 288(10):491-8. PubMed ID: 4567491
    [No Abstract]   [Full Text] [Related]  

  • 14. Quality assurance in the provision of hospital care. Trustees: the ultimate responsibility.
    Ainsworth TH
    Hospitals; 1974 Mar; 48(5):63 passim. PubMed ID: 4593005
    [No Abstract]   [Full Text] [Related]  

  • 15. Children's health insurance: the difference policy choices make.
    Holahan J; Uccello C; Feder J; Kim J
    Inquiry; 2000; 37(1):7-22. PubMed ID: 10892354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do public health activities pay for themselves? The effect of county-level public health expenditures on county-level public assistance medical care benefits in California.
    Brown TT; Murthy V
    Health Econ; 2020 Oct; 29(10):1220-1230. PubMed ID: 32618074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic impacts of Medicaid in North Carolina.
    Dumas C; Hall W; Garrett P
    N C Med J; 2008; 69(2):78-87. PubMed ID: 18605153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to HIV drug programs loses pace as need grows.
    AIDS Policy Law; 2002 Jul; 17(12):3. PubMed ID: 12134794
    [No Abstract]   [Full Text] [Related]  

  • 19. Public assistance patients deserve only the best prescription drugs.
    Knapp DA
    Am Pharm; 1979 Dec; 19(13):6-7. PubMed ID: 517426
    [No Abstract]   [Full Text] [Related]  

  • 20. Cost controls will help slow expenditures for health care in 1980s, Little's study predicts.
    Employee Benefit Plan Rev; 1977 Jul; 32(1):70-1. PubMed ID: 10304825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.